Stay updated on CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial
Sign up to get notified when there's something new on the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page.

Latest updates to the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page
- Check3 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check10 days agoChange DetectedA new NIH banner announces an agency-wide terminology transition and links to updates and FAQs. The study record content remains unchanged.SummaryDifference1%

- Check17 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check23 days agoChange DetectedThe site revision label in the footer changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record details with an access-restricted message. This indicates the page is currently unavailable rather than presenting the study information.SummaryDifference18%

- Check66 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a new release of the page template or platform updates. This appears to be a maintenance update rather than a modification to the study details.SummaryDifference0.1%

Stay in the know with updates to CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page.